<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bariatric Product Guide &#187; veterinary products</title>
	<atom:link href="http://www.bariatricproductguide.com/blog/tag/veterinary-products/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bariatricproductguide.com/blog</link>
	<description>A comprehensive guide to bariatric products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 08:51:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Stirling receives patent for its anti-obesity product</title>
		<link>http://www.bariatricproductguide.com/blog/2008/11/10/stirling-receives-patent-for-its-anti-obesity-product/</link>
		<comments>http://www.bariatricproductguide.com/blog/2008/11/10/stirling-receives-patent-for-its-anti-obesity-product/#comments</comments>
		<pubDate>Mon, 10 Nov 2008 06:56:02 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Anti-Obesity Drugs]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[R-salbutamol compound]]></category>
		<category><![CDATA[Stirling Products]]></category>
		<category><![CDATA[veterinary products]]></category>

		<guid isPermaLink="false">http://www.bariatricproductguide.com/blog/2008/11/10/stirling-receives-patent-for-its-anti-obesity-product/</guid>
		<description><![CDATA[Stirling Products has received the first approval for its patent application for &#8220;Methods of decreasing fat deposits and body weight in mammals and birds&#8221; in New Zealand. The patent relates to the use of the company&#8217;s R-salbutamol compound. The product has the potential to reduce body weight. CEO and Managing Director of Stirling Products, Dr [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bariatricproductguide.com/blog/wp-content/uploads/2008/11/stirling.png" align="left" height="122" hspace="5" vspace="5" width="200" /><a href="http://www.stirlingproducts.net/">Stirling Products</a> has received the first approval for its patent application for &#8220;Methods of decreasing fat deposits and body weight in mammals and birds&#8221; in New Zealand. The patent relates to the use of the company&#8217;s R-salbutamol compound. The product has the potential to reduce body weight. CEO and Managing Director of Stirling Products, Dr Calvin London said that he hoped that a series of approvals in other countries would follow. The company has already conducted studies for the compound on obese male Zucker rats.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bariatricproductguide.com/blog/2008/11/10/stirling-receives-patent-for-its-anti-obesity-product/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
